Published in J Am Soc Mass Spectrom on January 28, 2010
Top-down mass spectrometry: recent developments, applications and perspectives. Analyst (2011) 1.50
Characterization of green fluorescent proteins by 193 nm ultraviolet photodissociation mass spectrometry. Proteomics (2014) 1.50
Analysis of intact protein isoforms by mass spectrometry. J Biol Chem (2011) 1.15
Proteomics in epigenetics: new perspectives for cancer research. Brief Funct Genomics (2013) 0.84
Middle-Down and Top-Down Mass Spectrometric Analysis of Co-occurring Histone Modifications. Curr Protoc Protein Sci (2014) 0.82
Discovery of lysine post-translational modifications through mass spectrometric detection. Essays Biochem (2012) 0.82
The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development. Curr Mol Med (2016) 0.75
Chromatin modifications and their function. Cell (2007) 55.98
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature (2001) 19.67
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature (2001) 19.54
The mammalian epigenome. Cell (2007) 18.13
Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem (2003) 13.58
Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature (1995) 5.48
Automated reduction and interpretation of high resolution electrospray mass spectra of large molecules. J Am Soc Mass Spectrom (2000) 5.44
HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet (1994) 5.43
Signaling to chromatin through histone modifications. Cell (2000) 5.36
Probability-based validation of protein identifications using a modified SEQUEST algorithm. Anal Chem (2002) 3.86
Chemical derivatization of histones for facilitated analysis by mass spectrometry. Nat Protoc (2007) 3.78
Pervasive combinatorial modification of histone H3 in human cells. Nat Methods (2007) 3.54
Quantitative analysis of modified proteins and their positional isomers by tandem mass spectrometry: human histone H4. Anal Chem (2006) 3.08
Mass spectrometric characterization of human histone H3: a bird's eye view. J Proteome Res (2006) 2.29
Mass spectrometry identifies and quantifies 74 unique histone H4 isoforms in differentiating human embryonic stem cells. Proc Natl Acad Sci U S A (2008) 2.29
High level expression of the HMGI (Y) gene during embryonic development. Oncogene (1996) 2.13
One-pot shotgun quantitative mass spectrometry characterization of histones. J Proteome Res (2009) 2.13
Precise characterization of human histones in the H2A gene family by top down mass spectrometry. J Proteome Res (2006) 2.09
Characterization of histones and their post-translational modifications by mass spectrometry. Curr Opin Chem Biol (2006) 1.92
The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene (1995) 1.61
Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res (1989) 1.61
A mixed integer linear optimization framework for the identification and quantification of targeted post-translational modifications of highly modified proteins using multiplexed electron transfer dissociation tandem mass spectrometry. Mol Cell Proteomics (2009) 1.51
Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues. J Proteome Res (2007) 1.48
Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. J Biol Chem (1991) 1.39
Dynamic interaction of HMGA1a proteins with chromatin. J Cell Sci (2004) 1.27
Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res (1985) 1.27
Purification and postsynthetic modifications of Friend erythroleukemic cell high mobility group protein HMG-I. Anal Biochem (1986) 1.25
The AT-hook of the chromatin architectural transcription factor high mobility group A1a is arginine-methylated by protein arginine methyltransferase 6. J Biol Chem (2005) 1.21
Nepsilon-formylation of lysine is a widespread post-translational modification of nuclear proteins occurring at residues involved in regulation of chromatin function. Nucleic Acids Res (2007) 1.16
On the phosphorylation of low molecular mass HMG (high mobility group) proteins in Ehrlich ascites cells. FEBS Lett (1985) 1.12
High mobility group proteins and their post-translational modifications. Biochim Biophys Acta (2008) 1.09
Binding of HMG-I(Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor alpha gene. Mol Cell Biol (2000) 1.04
During apoptosis of tumor cells HMGA1a protein undergoes methylation: identification of the modification site by mass spectrometry. Biochemistry (2003) 1.04
Interaction of high mobility group-I (Y) nonhistone proteins with nucleosome core particles. J Biol Chem (1993) 1.03
Three distinct sub-nuclear populations of HMG-I protein of different properties revealed by co-localization image analysis. J Cell Sci (1998) 1.00
Substrate structure influences binding of the non-histone protein HMG-I(Y) to free nucleosomal DNA. Biochemistry (1996) 0.98
Differential in vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions. Biochemistry (2000) 0.97
A mass spectrometric study on the in vitro methylation of HMGA1a and HMGA1b proteins by PRMTs: methylation specificity, the effect of binding to AT-rich duplex DNA, and the effect of C-terminal phosphorylation. Biochemistry (2007) 0.97
Macroscopic differences in HMGA oncoproteins post-translational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding properties. J Proteome Res (2009) 0.93
Acetylation and phosphorylation of high-mobility group A1 proteins in PC-3 human tumor cells. Biochemistry (2006) 0.91
HMGA proteins: isolation, biochemical modifications, and nucleosome interactions. Methods Enzymol (2004) 0.90
Tandem mass spectrometry for the examination of the posttranslational modifications of high-mobility group A1 proteins: symmetric and asymmetric dimethylation of Arg25 in HMGA1a protein. Biochemistry (2005) 0.90
Intranuclear distribution of HMGI/Y proteins. An immunocytochemical study. J Histochem Cytochem (1998) 0.88
In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential. Biochemistry (2004) 0.88
A quantitative study on the in vitro and in vivo acetylation of high mobility group A1 proteins. J Am Soc Mass Spectrom (2007) 0.88
Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins. J Biol Chem (2004) 0.85
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med (2012) 11.14
Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature (2005) 6.40
Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science (2013) 6.29
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med (2011) 3.82
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat Chem Biol (2011) 3.60
Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell (2008) 3.09
Expression patterns and post-translational modifications associated with mammalian histone H3 variants. J Biol Chem (2005) 3.00
SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature (2012) 2.96
Asymmetrically modified nucleosomes. Cell (2012) 2.79
High throughput characterization of combinatorial histone codes. Mol Cell Proteomics (2009) 2.52
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature (2010) 2.49
Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell (2012) 2.39
In vivo residue-specific histone methylation dynamics. J Biol Chem (2009) 2.33
Mass spectrometry analysis of Arabidopsis histone H3 reveals distinct combinations of post-translational modifications. Nucleic Acids Res (2004) 2.28
NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Mol Cell (2011) 2.27
Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell (2009) 2.27
Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development. Nature (2010) 2.20
One-pot shotgun quantitative mass spectrometry characterization of histones. J Proteome Res (2009) 2.13
Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling. Nat Immunol (2010) 2.07
A Comparative Theoretical and Computational Study on Robust Counterpart Optimization: I. Robust Linear Optimization and Robust Mixed Integer Linear Optimization. Ind Eng Chem Res (2011) 1.98
The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation. Mol Cell (2011) 1.96
Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database. Sci Rep (2011) 1.92
Retracted Branched tricarboxylic acid metabolism in Plasmodium falciparum. Nature (2010) 1.92
Serine 31 phosphorylation of histone variant H3.3 is specific to regions bordering centromeres in metaphase chromosomes. Proc Natl Acad Sci U S A (2005) 1.91
Examining histone posttranslational modification patterns by high-resolution mass spectrometry. Methods Enzymol (2012) 1.83
Proteome-wide prediction of acetylation substrates. Proc Natl Acad Sci U S A (2009) 1.81
Histone H3 lysine 56 methylation regulates DNA replication through its interaction with PCNA. Mol Cell (2012) 1.79
A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. Genes Dev (2006) 1.70
Functional analysis of the subunits of the chromatin assembly factor RSF. Mol Cell Biol (2003) 1.56
Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex. EMBO J (2007) 1.55
A mixed integer linear optimization framework for the identification and quantification of targeted post-translational modifications of highly modified proteins using multiplexed electron transfer dissociation tandem mass spectrometry. Mol Cell Proteomics (2009) 1.51
The significance, development and progress of high-throughput combinatorial histone code analysis. Cell Mol Life Sci (2010) 1.51
Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification. J Biol Chem (2006) 1.50
Chromatin-specific remodeling by HMGB1 and linker histone H1 silences proinflammatory genes during endotoxin tolerance. Mol Cell Biol (2009) 1.49
Combinatorial profiling of chromatin binding modules reveals multisite discrimination. Nat Chem Biol (2010) 1.39
Breaking the histone code with quantitative mass spectrometry. Expert Rev Proteomics (2011) 1.39
Heterochromatin protein 1 is extensively decorated with histone code-like post-translational modifications. Mol Cell Proteomics (2009) 1.39
Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency. Nat Cell Biol (2013) 1.33
Tandem mass spectrometry with ultrahigh mass accuracy clarifies peptide identification by database retrieval. J Proteome Res (2009) 1.33
H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence. Proc Natl Acad Sci U S A (2012) 1.28
Integrated computational and experimental approach for lead optimization and design of compstatin variants with improved activity. J Am Chem Soc (2003) 1.28
Chromatin proteins captured by ChIP-mass spectrometry are linked to dosage compensation in Drosophila. Nat Struct Mol Biol (2013) 1.26
Proteomic characterization of novel histone post-translational modifications. Epigenetics Chromatin (2013) 1.26
Nucleolin is required for RNA polymerase I transcription in vivo. Mol Cell Biol (2006) 1.23
Global secretome analysis identifies novel mediators of bone metastasis. Cell Res (2012) 1.22
Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation. Epigenetics (2012) 1.19
Quantitative dynamics of the link between cellular metabolism and histone acetylation. J Biol Chem (2013) 1.19
Ab initio prediction of the three-dimensional structure of a de novo designed protein: a double-blind case study. Proteins (2005) 1.18
Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins. Genome Biol (2012) 1.18
Origins and formation of histone methylation across the human cell cycle. Mol Cell Biol (2012) 1.16
Simian virus 40 small t antigen mediates conformation-dependent transfer of protein phosphatase 2A onto the androgen receptor. Mol Cell Biol (2005) 1.13
Analysis of histones in Xenopus laevis. II. mass spectrometry reveals an index of cell type-specific modifications on H3 and H4. J Biol Chem (2008) 1.12
De novo peptide identification via tandem mass spectrometry and integer linear optimization. Anal Chem (2007) 1.12
Mild performic acid oxidation enhances chromatographic and top down mass spectrometric analyses of histones. Mol Cell Proteomics (2007) 1.11
Methylation of H4 lysines 5, 8 and 12 by yeast Set5 calibrates chromatin stress responses. Nat Struct Mol Biol (2012) 1.11
A novel approach for untargeted post-translational modification identification using integer linear optimization and tandem mass spectrometry. Mol Cell Proteomics (2010) 1.11
Protein quantification across hundreds of experimental conditions. Proc Natl Acad Sci U S A (2009) 1.10
ATRX-mediated chromatin association of histone variant macroH2A1 regulates α-globin expression. Genes Dev (2012) 1.10
Large-scale global identification of protein lysine methylation in vivo. Epigenetics (2013) 1.09
Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation. Nat Commun (2013) 1.08
A Comparative Theoretical and Computational Study on Robust Counterpart Optimization: II. Probabilistic Guarantees on Constraint Satisfaction. Ind Eng Chem Res (2012) 1.07
Biclustering via optimal re-ordering of data matrices in systems biology: rigorous methods and comparative studies. BMC Bioinformatics (2008) 1.07
A quantitative atlas of histone modification signatures from human cancer cells. Epigenetics Chromatin (2013) 1.06
The adenovirus L4 33-kilodalton protein binds to intragenic sequences of the major late promoter required for late phase-specific stimulation of transcription. J Virol (2006) 1.05
De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation. J Med Chem (2012) 1.04
Histone H1 variant-specific lysine methylation by G9a/KMT1C and Glp1/KMT1D. Epigenetics Chromatin (2010) 1.03
Toward full-sequence de novo protein design with flexible templates for human beta-defensin-2. Biophys J (2007) 1.03
BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection. Proc Natl Acad Sci U S A (2012) 1.01
H4K20 methylation regulates quiescence and chromatin compaction. Mol Biol Cell (2013) 0.99
On the histone lysine methyltransferase activity of fungal metabolite chaetocin. J Med Chem (2013) 0.99
Single cell analysis of transcriptional activation dynamics. PLoS One (2010) 0.99
H3R42me2a is a histone modification with positive transcriptional effects. Proc Natl Acad Sci U S A (2013) 0.97
A hybrid method for peptide identification using integer linear optimization, local database search, and quadrupole time-of-flight or OrbiTrap tandem mass spectrometry. J Proteome Res (2008) 0.97
Systems-wide proteomic characterization of combinatorial post-translational modification patterns. Expert Rev Proteomics (2010) 0.96
Negative regulation of LRP6 function by casein kinase I epsilon phosphorylation. J Biol Chem (2006) 0.96
Microarray data mining: a novel optimization-based approach to uncover biologically coherent structures. BMC Bioinformatics (2008) 0.95
Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity. J Biol Chem (2011) 0.95
Evaluation of normalization and pre-clustering issues in a novel clustering approach: global optimum search with enhanced positioning. J Bioinform Comput Biol (2007) 0.95